There is a "high degree of uncertainty" over how much of the hundreds of millions of pounds lent to sports bodies during the ...
MILAN (Reuters) -Italian drugmaker Angelini Pharma is keen on M&A, even after its offer to buy bigger rival Recordati fell through despite having the support of potential financial partners, its Chief ...